Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00445367 · ClinicalTrials.gov registry record

Biobank For MS And Other Demyelinating Diseases

A clinical trial of Multiple Sclerosis and Neuromyelitis Optica, sponsored by Accelerated Cure Project for Multiple Sclerosis.

Active
Registry status
3,226
Enrollment target
10
Study locations

NCT00445367: Active study of Multiple Sclerosis and Neuromyelitis Optica, sponsored by Accelerated Cure Project for Multiple Sclerosis.

NCT00445367 is a study of Multiple Sclerosis and Neuromyelitis Optica that is active but no longer recruiting, run by Accelerated Cure Project for Multiple Sclerosis. The registered enrollment target is 3,226 participants, above the 575-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (461% higher). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00445367, a study of Multiple Sclerosis and Neuromyelitis Optica, is active but no longer recruiting, sponsored by Accelerated Cure Project for Multiple Sclerosis.

ACTIVE NOT RECRUITING
Registry status
3,226 participants
Enrollment target
10
Study locations

Study Summary

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Study Locations (10)

Massachusetts

  • Beth Israel Deaconess - Boston
  • University of Massachusetts Medical School - Worcester

Arizona

  • Barrow Neurological Institute - Phoenix

California

  • Stanford University - Stanford

Colorado

  • The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver - Aurora

Georgia

  • Shepherd Center - Atlanta

Maryland

  • Johns Hopkins - Baltimore

New York

  • Multiple Sclerosis Research Center of New York - New York

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 3,226 participants
Start Date 2006-05
Est. Completion 2036-10

What the registry record for NCT00445367 still lists

NCT00445367 is an observational study that tracks outcomes without assigning an intervention. Its 3,226 participants enrollment target places it among the larger protocols in the corpus, above the 575-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (461% higher).

The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00445367 lists 10 locations in 9 states (Massachusetts, Arizona, California).

Frequently Asked Questions

What is clinical trial NCT00445367 about?

NCT00445367 is a clinical study titled "Biobank For MS And Other Demyelinating Diseases". To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelat...

What is the current status of trial NCT00445367?

This trial is currently active not recruiting. The enrollment target is 3,226 participants. The study started on 2006-05. Estimated completion is 2036-10.

What conditions does trial NCT00445367 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Neuromyelitis Optica, Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis.

Who is sponsoring clinical trial NCT00445367?

This trial is sponsored by Accelerated Cure Project for Multiple Sclerosis, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00445367 being conducted?

This trial has 10 study locations across Arizona, California, Colorado, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00445367's enrollment target sits among peer trials

3,226 10th of 315 higher than 306 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06587529 · 3,218 participants · NA

    Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children

  • NCT06760507 · 3,209 participants · NA

    Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

  • NCT06953375 · 3,250 participants · NA

    Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty

  • NCT02043457 · 3,200 participants

    Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00445367, the US trial registry maintained by the National Library of Medicine. NCT00445367 (large enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.